A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 101–200 of 912
Juneja, R., Roudebush, C. P., Nasraway, S. A., Golas, A. A., Jacobi, J., Carroll, J., Nelson, D., Abad, V. J., & Flanders, S. J. (2009) · Critical Care · doi:10.1186/cc8129 · Cited by 86
“Several large randomized controlled trials were stopped due to unacceptably high rates of severe hypoglycemia (blood glucose (BG) 9 ] and 17.0% of the tight control group in the Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) study [10].”
BackgroundMethodResultInfluentialMild hypoglycemia is strongly associated with increased intensive care unit length of stay
Krinsley, J., Schultz, M. J., Spronk, P. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J.-C. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-49 · Cited by 82
“Arabi et al. analyzed severe hypoglycemic events (BG < 40 mg/dL) that occurred in their randomized, controlled trial of IIT [9].”
BackgroundMethodInfluentialSelf-citationFayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85
Gunst, J., De Bruyn, A., & Van den Berghe, G. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000706 · Cited by 84
Bláha, J., Mráz, M., Kopecký, P., Stříteský, M., Lipš, M., Matias, M., Kunstýř, J., Pořízka, M., Kotulák, T., Kolníková, I., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1959 · Cited by 83
Siegelaar, S. E., Hermanides, J., Oudemans-van Straaten, H. M., van der Voort, P. H., Bosman, R. J., Zandstra, D. F., & DeVries, J. H. (2010) · Critical Care · doi:10.1186/cc9369 · Cited by 82
“Other studies of IIT also did not reach their target range, illustrating the difficult implementation of this therapy [10,12,13].”
BackgroundMethodInfluentialGlucose Control in the ICU: A Continuing Story
Preiser, J., Chase, J. G., Hovorka, R., Joseph, J. I., Krinsley, J. S., Block, C. E. M. D., Desaive, T., Foubert, L. A., Kalfon, P., Pielmeier, U., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816648713 · Cited by 88
“The large studies cited above, assessing the possible place of tight glucose control in critical care, all used intermittent blood glucose monitoring.(2,4,5) Yet, human physiology is continuous not sporadic, making continuous monitoring of any variable more physiologically relevant than intermittent measures.”
BackgroundSelf-citationMupirocin: a topical antibiotic with a unique structure and mechanism of action.
PARENTI, M. A., Hatfield, S. M., & Leyden, J. J. (1987) · PubMed · Cited by 109
Chase, J. G., Compte, A. J. L., Preiser, J.-C., Shaw, G. M., Penning, S., & Desaive, T. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-11 · Cited by 88
“In Suhaimi et al [50] the multi-center Glucontrol trial [12] protocol was evaluated versus the control achieved with the Specialized Relative Insulin and Nutrition Titration (SPRINT) [58] protocol.”
BackgroundMethodSelf-citationAberegg, S. K. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.001 · Cited by 117
Erdman, J. W., Oria, M. P., & Pillsbury, L. (2011) · Cited by 98
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Dysglycaemia in the critically ill – significance and management
Deane, A. M., & Horowitz, M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12078 · Cited by 81
“Leuven Study I, Intensive Insulin Therapy in Critically Ill Patients [15]; Leuven Study II, Intensive Insulin Therapy in the Medical ICU [7]; German Competence Network Sepsis Group, Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) [19]; The NICE-SUGAR Study Investigators, Intensive versus C…”
BackgroundMethodDexamethasone, light anaesthesia, and tight glucose control (DeLiT) randomized controlled trial
Abdelmalak, B., Bonilla, A. M., Mascha, E. J., Maheshwari, A., Tang, W. H. W., You, J., Ramachandran, M. A., Kirkova, Y., Clair, D., Walsh, R. M., et al. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet050 · Cited by 82
The clinical impact of inpatient hypoglycemia
Brutsaert, E. F., Carey, M., & Zonszein, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.002 · Cited by 78
“7% in the tight control groups (Brunkhorst et al., 2008; NICE-SUGAR Study Investigators, 2009; Preiser et al., 2009; Van den Berghe et al., 2006, 2001).”
BackgroundInfluentialDubois, J., Herpe, T. V., van Hooijdonk, R. T. M., Wouters, R., Coart, D., Wouters, P. J., Assche, A. V., Veraghtert, G., Moor, B. D., Wauters, J., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1799-6 · Cited by 78
Bellaver, P., Schaeffer, A. F., Dullius, D. P., Viana, M. V., Leitão, C. B., & Rech, T. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-55080-3 · Cited by 77
Infectious Complications of Cardiac Surgery: A Clinical Review
Cove, M. E., Spelman, D. W., & MacLaren, G. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2012.04.021 · Cited by 87
Kurtz, P., Claassen, J., Helbok, R., Schmidt, J. M., Fernández-Salazar, L. I., Presciutti, M., Stuart, R. M., Connolly, E. S., Lee, K., Badjatia, N., et al. (2014) · Critical Care · doi:10.1186/cc13857 · Cited by 81
“Tight glucose control with intravenous insulin has been shown to reduce mortality among surgical ICU patients [5,6], but not in mixed populations of critically ill patients [7-10].”
BackgroundPrevalence and Impact of Unknown Diabetes in the ICU
Carpenter, D. L., Gregg, S. R., Xu, K., Buchman, T. G., & Coopersmith, C. M. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001353 · Cited by 69
Generalisability of a Virtual Trials Method for Glycaemic Control in Intensive Care
Dickson, J. L., Stewart, K. W., Pretty, C. G., Flechet, M., Desaive, T., Penning, S., Lambermont, B. C., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2686432 · Cited by 73
Continuous glucose monitors prove highly accurate in critically ill children
Bridges, B. C., Preissig, C. M., Maher, K. O., & Rigby, M. R. (2010) · Critical Care · doi:10.1186/cc9280 · Cited by 69
“Several recent, large multi-center randomized controlled trials (RCTs), including the Glucontrol, VISEP, and NICE-SUGAR trials, have been plagued with unacceptably high rates of hypoglycemia in strict control arms [5-7].”
BackgroundLanspa, M. J., Krinsley, J. S., Hersh, A. M., Wilson, E. L., Holmen, J. R., Orme, J. F., Morris, A. H., & Hirshberg, E. L. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.016 · Cited by 73
Untangling glycaemia and mortality in critical care
Uyttendaele, V., Dickson, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2017) · Critical Care · doi:10.1186/s13054-017-1725-y · Cited by 75
“In the first case, two cohorts and protocols (Glucontrol [14] and SPRINT [10]) from Liège, Belgium, and Christchurch, New Zealand, were simulated with both protocols, and their glycaemic level and variability were compared with those obtained clinically.”
MethodExpert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 73
Signal, M., Le Compte, A., Shaw, G. M., & Chase, J. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600506 · Cited by 68
Lanspa, M. J., Hirshberg, E. L., Phillips, G. D., Holmen, J. R., Stoddard, G. J., & Orme, J. F. (2012) · CHEST Journal · doi:10.1378/chest.12-2072 · Cited by 73
Endocrine and Metabolic Alterations in Sepsis and Implications for Treatment
Ingels, C., Gunst, J., & den Berghe, G. V. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.006 · Cited by 71
Glycemic Control in the Intensive Care Unit and during the Postoperative Period
Lena, D., Kalfon, P., Preiser, J., Ichaï, C., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182078843 · Cited by 69
Self-citationMeynaar, I. A., Eslami, S., Abu–Hanna, A., der Voort, P. V., de Lange, D. W., & de Keizer, N. F. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.11.004 · Cited by 77
“However, subsequent studies did not confirm a survival benefit [2,3], and the largest and most recent randomized multicenter study even showed a worse outcome for patients with tight glycemic control (4.”
ResultShetty, S., Inzucchi, S. E., Goldberg, P. A., Cooper, D. A., Siegel, M. D., & Honiden, S. (2011) · Endocrine Practice · doi:10.4158/ep11260.or · Cited by 73
Suhaimi, F. M., Compte, A. L., Preiser, J., Shaw, G. M., Massion, P. B., Radermecker, R. P., Pretty, C. G., Lin, J., Desaive, T., & Chase, J. G. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400208 · Cited by 68
“Hence, the result for the intensively controlled Group A would have been even further hypoglycemia and even more variable control around the target level when run over multiple centres, as was indeed the case in the final multi-centre report [29] with 8.”
BackgroundMethodResultInfluentialSelf-citationDysglycemia and Glucose Control During Sepsis
Plummer, M. P., & Deane, A. M. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.010 · Cited by 69
The new sepsis definition: limitations and contribution to research and diagnosis of sepsis
Verdonk, F., Blet, A., & Mebazaa, A. (2017) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000446 · Cited by 67
Krinsley, J. S., Preiser, J., & Hirsch, I. B. (2016) · Endocrine Practice · doi:10.4158/ep161532.or · Cited by 66
Self-citationManagement of hyperglycemia in hospitalized patients
Smiley, D., & Umpierrez, G. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05805.x · Cited by 64
Glucose control in critical care
Clain, J. M., Ramar, K., & Surani, S. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i9.1082 · Cited by 65
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 68
Self-citationIs intensive glucose control bad for critically ill patients? A systematic review and meta-analysis
Yao, R.-Q., Ren, C., Wu, G., Zhu, Y., Xia, Z., & Yao, Y.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.43447 · Cited by 70
“A total of 27 trials reported evidence of length of ICU stay[9, 11, 12, 42-44, 46, 52, 53, 55, 56, 59-61, 63, 65-67, 69, 72, 75, 80, 85, 87-89, 92].”
BackgroundMethodInfluentialInpatient Management of Diabetes and Hyperglycemia
Bogun, M. M., & Inzucchi, S. E. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.008 · Cited by 67
Blood Glucose Control in the Intensive Care Unit: Benefits and Risks
Gunst, J., & den Berghe, G. V. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00702.x · Cited by 65
Glucose management in critically ill adults and children
Mesotten, D., Preiser, J., & Kosiborod, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00223-5 · Cited by 63
Self-citationLing, Y., Li, X., & Gao, X. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.02.013 · Cited by 69
Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis
Yeh, J. S., Sung, S., Huang, H.-M., Yang, H.-L., You, L., Chuang, S., Huang, P.-C., Hsu, P., Cheng, H., & Chen, C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0803-3 · Cited by 66
“Moreover, this systematic review further confirms the association between hypoglycemia and clinical outcomes among patients without diabetes, and patients receiving intensive care for critical illness [2, 17, 40–42, 44, 45], and also provided an explanation for the less than expected benefit of intensive blood sugar c…”
BackgroundResultLiberal Glucose Control in ICU Patients With Diabetes: A Before-and-After Study*
Luethi, N., Cioccari, L., Biesenbach, P., Lucchetta, L., Kagaya, H., Morgan, R., Muzio, F. D., Presello, B., Gaafar, D., Hay, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003087 · Cited by 61
“Yet, we observed a greater proportion of glucose values within target range than reported in a previous trial (20).”
BackgroundPoole, A. P., Finnis, M., Anstey, J. R., Bellomo, R., Bihari, S., Biradar, V., Doherty, S., Eastwood, G. M., Finfer, S. R., French, C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0329oc · Cited by 63
Stress Hyperglycemia in Pediatric Critical Illness: The Intensive Care Unit Adds to the Stress!
Srinivasan, V. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600106 · Cited by 61
Relationship between hypoglycemia and mortality in critically ill children*
Faustino, E. V. S., & Bogue, C. W. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181e8f502 · Cited by 60
“Increased rates of hypoglycemia in prematurely terminated trials on glycemic control (2, 4, 23) may not necessarily result in increased mortality in insulin-treated patients compared to patients with spontaneous hypoglycemia.”
BackgroundVan Steen, S., Rijkenberg, S., Limpens, J., Van der Voort, P., Hermanides, J., & DeVries, J. (2017) · Sensors · doi:10.3390/s17010146 · Cited by 59
Dungan, K. M., Binkley, P., Nagaraja, H. N., Schuster, D., & Osei, K. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1155 · Cited by 57
“The observation carries ramifications for choosing glycaemic targets for various patient populations and for comparing studies, as past guidelines [33] and design of multicenter prospective trials [18,34] have been based on studies that report morning glucose values.”
BackgroundManagement of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient
Davidson, P., Kwiatkowski, C. A., & Wien, M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615591057 · Cited by 57
Surviving Sepsis After Burn Campaign
Greenhalgh, D. G., Hill, D. M., Burmeister, D. M., Gus, E. I., Cleland, H. J., Padiglione, A. A., Holden, D., Huss, F. R. M., Chew, M. S., Kubasiak, J., et al. (2023) · Burns · doi:10.1016/j.burns.2023.05.003 · Cited by 65
Glycaemic variability, infections and mortality in a medical–surgical intensive care unit
Donati, A., Damiani, E., Domizi, R., Botticelli, L., Castagnani, R., Gabbanelli, V., Nataloni, S., Carsetti, A., Scorcella, C., Adrario, E., et al. (2014) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01437-0 · Cited by 69
Self-citationKopecký, P., Mráz, M., Bláha, J., Lindner, J., Svačina, Š., Hovorka, R., & Haluzík, M. (2013) · BioMed Research International · doi:10.1155/2013/186439 · Cited by 55
“These findings are of major importance in the light of recent large multicentric studies aiming at tight glucose control, which were discontinued due to excessive risk of hypoglycemia—the Glucontrol and the VISEP study [5, 7]—and particularly the NICE-SUGAR trial, where intensive insulin treatment targeted at normal g…”
BackgroundHunninghake, G. W., Doerschug, K. C., Nymon, A. B., Schmidt, G. A., Meyerholz, D. K., & Ashare, A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1757oc · Cited by 58
Hyperglycemia and Acute Kidney Injury During the Perioperative Period
Mendez, C. E., Mesropian, P. J. D., Mathew, R. O., & Slawski, B. A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0701-7 · Cited by 59
Thirty years of critical care medicine
Vincent, J., Singer, M., Marini, J. J., Moreno, R. P., Levy, M. M., Matthay, M. A., Pinsky, M. R., Rhodes, A., Ferguson, N. D., Evans, T. W., et al. (2010) · Critical Care · doi:10.1186/cc8979 · Cited by 63
“• Tight blood g lucose control was widely adopted after the single-center study results of Van den Berghe and colleagues [3], but multicenter studies later suggested that perhaps it was not such an easy approach to apply [4-6] and highlighted the diffi culty of translating single-study results to the wider ICU populat…”
MethodInfluentialSelf-citationClinical review: Glucose control in severely burned patients - current best practice
Jeschke, M. G. (2013) · Critical Care · doi:10.1186/cc12678 · Cited by 56
“Lastly, various metaanalyses did not show any benefi t associated with insulin therapy; and Preiser and colleagues even suggest ed that it is not the insulin per se but the protocolized care that improved outcome of tight euglycemic control [28].”
Continuous Insulin Infusion: When, Where, and How?
Kelly, J. L. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.218 · Cited by 60
Kesavadev, J., Misra, A., Saboo, B., Aravind, S. R., Hussain, A., Czupryniak, L., & Raz, I. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.032 · Cited by 60
“study) [40] Prospective Blood glucose Target blood glucose in”
BackgroundGlucose control positively influences patient outcome: A retrospective study
Penning, S., Pretty, C. G., Preiser, J., Shaw, G. M., Desaive, T., & Chase, J. G. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.12.013 · Cited by 61
“Glucontrol: a randomized multicenter study, admitted to ICUs from 3rd November 2004 to 30th May 2006 (N = 917) [9].”
BackgroundSelf-citationChase, J. G., Desaive, T., Bohé, J., Cnop, M., Block, C. E. M. D., Gunst, J., Hovorka, R., Kalfon, P., Krinsley, J. S., Renard, É., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2110-1 · Cited by 58
Self-citationSchultz, M. J., Harmsen, R. E., & Spronk, P. E. (2010) · Critical Care · doi:10.1186/cc8966 · Cited by 53
“In addition, an increase was noticed in the number of patients who received insulin, or there was an increase in the amount of infused insulin in the control group [2-7].”
BackgroundMethodResultInfluentialLiberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study
Kar, P., Plummer, M. P., Bellomo, R., Jenkins, A. J., Januszewski, A. S., Chapman, M. J., Jones, K. L., Horowitz, M., & Deane, A. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001815 · Cited by 54
“Meanwhile inferences from interventional studies are limited for patients with chronic hyperglycemia as investigations so far have enrolled patients regardless of preexisting diabetes and these studies were never powered to detect differences in the subgroup of patients with diabetes (22, 29, 30).”
BackgroundFriedrich, J. O., Chant, C., & Adhikari, N. K. (2010) · Critical Care · doi:10.1186/cc9240 · Cited by 53
Update on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 58
“In the GluControl trial [17], the mortality did not differ between the randomly assigned groups and in the Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation [16], tight BG control was associated with an increase of the 90-d mortality from 24.”
MethodSelf-citationVergès, B. L., Avignon, A., Bonnet, F., Catargi, B., Cattan, S., Cosson, E., Ducrocq, G., Elbaz, M., Fredenrich, A., Gourdy, P., et al. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.003 · Cited by 55
“7%), and a non-significant trend towards higher 28-day morality and in-hospital mortality [38].”
BackgroundTransition From Intravenous to Subcutaneous Insulin
Avanzini, F., Marelli, G., Donzelli, W., Busi, G., Carbone, S., Bellato, L., Colombo, E. L., Foschi, R., Riva, E., Roncaglioni, M. C., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2023 · Cited by 50
Relative Hypoglycemia in Diabetic Patients With Critical Illness
Kwan, T. N., Hessels, L., Marhoon, N., Robbins, R., Mårtensson, J., Ekinci, E. I., & Bellomo, R. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004213 · Cited by 53
Diabetes Care After Transplant
Wallia, A., Illuri, V., & Molitch, M. E. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.005 · Cited by 50
Glycemic control in the critically ill: Less is more
Alhatemi, G., Aldiwani, H., Alhatemi, R., Hussein, M., Mahdai, S., & Seyoum, B. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.20171 · Cited by 53
“Subsequent trials—medical Leuven, 14 VISEP, 15 Glucontrol, 16 and NICE-SUGAR 17 — used both arterial and capillary analyzers.”
InfluentialDe Block, C. E. M., Gios, J., Verheyen, N., Manuel-y-Keenoy, B., Rogiers, P., Jorens, P. G., Scuffi, C., & Van Gaal, L. F. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0151 · Cited by 50
Impact of Hypoglycemia in Hospitalized Patients
Carey, M., Boucai, L., & Zonszein, J. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0336-x · Cited by 56
Park, S., Kim, D.-G., Suh, G. Y., Kang, J. G., Ju, Y.-S., Lee, Y.-J., Park, J. Y., Lee, S. W., & Jung, K.-S. (2012) · Critical Care · doi:10.1186/cc11674 · Cited by 47
“Since van den Berghe and colleagues demonstrated in the second Leuven study that severe hypoglycemia (blood glucose (BG) < 40 mg/dl) is associated with mortality [1], subsequent multicentre studies (Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) and GLUCONTROL trials) have identified a hi…”
BackgroundThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Hypoglycaemia: current management and controversies
Choudhary, P., & Amiel, S. A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.068197 · Cited by 47
“However, subsequent larger multicentre studies of tight glucose control in the critically ill”
BackgroundLorencio, C., Leal, Y., Bonet, A., Bondía, J., Palerm, C. C., Taché, A., Sirvent, J.-M., & Vehí, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0008 · Cited by 49
Perioperative management of adult diabetic patients. Intraoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.018 · Cited by 55
Insulin Therapy in Hospitalized Patients
Pérez, A., Ramos, A., & Carreras, G. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001078 · Cited by 45
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Mendez, C. E., & Umpierrez, G. E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.180 · Cited by 46
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Hyper/hypoglycemia and acute kidney injury in critically ill patients
Fiaccadori, E., Sabatino, A., Morabito, S., Bozzoli, L., Donadio, C., Maggiore, U., & Regolisti, G. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.04.006 · Cited by 47
“Finally, in the GLUCOCONTROL study [51], in which patients were randomized to IIT (80e110 mg/dl [4.”
MethodWernly, B., Lichtenauer, M., Hoppe, U. C., & Jung, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.24 · Cited by 47
“In a summary of five studies (15,18-21) comparing tight glucose control (blood glucose between 80–110 mg/dL) to control groups, an increased risk of death was reported for intensive insulin therapy and the control group showed better survival (OR 0.”
BackgroundAbuannadi, M., Kosiborod, M., Riggs, L. A., House, J. A., Hamburg, M. S., Kennedy, K. F., & Marso, S. P. (2012) · Endocrine Practice · doi:10.4158/ep12196.or · Cited by 46
Kohl, B., Hammond, M. S., Cucchiara, A. J., & Ochroch, E. A. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.06.021 · Cited by 46
“36 6/2 [2-14] 5/4 [2-10] 4 0.”
Kalfon, P., Le Manach, Y., Ichai, C., Bréchot, N., Cinotti, R., Dequin, P.-F., Riu-Poulenc, B., Montravers, P., Annane, D., Dupont, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0851-7 · Cited by 45
“It should be pointed out that such a discrepancy between mortality rate (unchanged) and hypoglycemia rate (increased) was also observed in all previous major trials [4-6], except one [8], excluding the first trial performed during an era without any blood glucose control performed in the control group [3].”
BackgroundResultSelf-citationReexamining the evidence for inpatient glucose control: New recommendations for glycemic targets
Moghissi, E. S. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100171 · Cited by 48
Wallia, A., Schmidt, K., Johnson Oakes, D., Pollack, T., Welsh, N., Kling-Colson, S., Gupta, S., Fulkerson, C., Aleppo, G., Parikh, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3279 · Cited by 42
Glycemic control in the intensive care unit: A control systems perspective
Chase, J. G., Benyó, B. I., & Desaive, T. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.03.007 · Cited by 50
“[40-43, 52], but several studies could not repeat these results [53-63].”
Hagerf, B. V., Protuš, M., Németová, L., Mráz, M., Kieslichová, E., Uchytilová, E., Indrova, V., Lelito, J., Girman, P., Haluzík, M., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1663 · Cited by 49
Deakin, C. D., Nolan, J. P., Soar, J., Sunde, K., Koster, R. W., Smith, G. B., & Perkins, G. D. (2010) · Notfall + Rettungsmedizin · doi:10.1007/s10049-010-1370-3 · Cited by 59
Schierenbeck, F., Öwall, A., Franco‐Cereceda, A., & Liška, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0169 · Cited by 45
Glycemic Targets and Approaches to Management of the Patient with Critical Illness
Mesotten, D., & den Berghe, G. V. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0241-8 · Cited by 48
Machine-learning-derived sepsis bundle of care
Kalimouttou, A., Lerner, I., Cheurfa, C., Jannot, A., & Pirracchio, R. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06928-2 · Cited by 50
Kurtz, P., Claassen, J., Schmidt, J. M., Helbok, R., Hanafy, K. A., Presciutti, M., Lantigua, H., Connolly, E. S., Lee, K., Badjatia, N., et al. (2013) · Neurocritical Care · doi:10.1007/s12028-013-9919-x · Cited by 47
Penning, S., Chase, J. G., Preiser, J., Pretty, C. G., Signal, M., Mélot, C., & Desaive, T. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.01.013 · Cited by 48
“This study evaluates the impact and interaction of organ failure and glycemic control in the Glucontrol trial [10] that compared separate glycemic target bands, one of which is entirely within the 4.”
BackgroundResultInfluentialSelf-citationHiperglucemia de estrés y su control con insulina en el paciente crítico: evidencia actual
Manzanares, W., & Aramendi, I. (2009) · Medicina Intensiva · doi:10.1016/j.medin.2009.10.003 · Cited by 66
Accuracy of Blood Glucose Measurement and Blood Glucose Targets
Eerdekens, G.-J., Rex, S., & Mesotten, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905581 · Cited by 46
Krinsley, J. S., & Fisher, M. C. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.967 · Cited by 43
Mirabile, A., Numico, G., Russi, E. G., Bossi, P., Crippa, F., Bacigalupo, A., Sanctis, V. D., Musso, S., Merlotti, A. M., Ghi, M. G., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.03.003 · Cited by 43
“[176] Preiser J-C, Devos P, Ruiz-Santana S, et al.”
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.